We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+17.17%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$5.99B
AUM Growth
+$838M
Cap. Flow
+$75.2M
Cap. Flow %
1.26%
Top 10 Hldgs %
14.39%
Holding
1,189
New
99
Increased
492
Reduced
540
Closed
55

Sector Composition

Rank Sector Weight
1 Technology 20.78%
2 Financials 14.29%
3 Healthcare 13.91%
4 Consumer Discretionary 9.78%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHL
626
DELISTED
China Mobile Limited
CHL
$1.21M 0.02%
42,377
-65,731
-61% -$2.03M
IRTC icon
627
iRhythm Holdings
IRTC
$4.1B
$1.21M 0.02%
5,092
-443
-8% -$101K
AYI icon
628
Acuity Brands
AYI
$10.6B
$1.2M 0.02%
9,899
-614
-6% -$65.9K
HPP
629
Hudson Pacific Properties
HPP
$740M
$1.2M 0.02%
7,129
+620
+10% +$102K
FRME icon
630
First Merchants
FRME
$2.66B
$1.2M 0.02%
31,975
-3,021
-9% -$93.8K
CDP icon
631
COPT Defense Properties
CDP
$4.14B
$1.19M 0.02%
45,736
-3,049
-6% -$76.9K
BALL icon
632
Ball Corp
BALL
$16.6B
$1.19M 0.02%
12,731
-3,167
-20% -$293K
DLB icon
633
Dolby
DLB
$5.82B
$1.18M 0.02%
12,182
+2,169
+22% +$179K
SPHB icon
634
Invesco S&P 500 High Beta ETF
SPHB
$926M
$1.18M 0.02%
20,800
-463
-2% -$23.1K
MPT
635
Medical Properties Trust
MPT
$2.48B
$1.18M 0.02%
54,079
-5,932
-10% -$116K
BHC icon
636
Bausch Health
BHC
$2.37B
$1.18M 0.02%
56,516
+11,916
+27% +$222K
FITB
637
Fifth Third Bancorp
FITB
$51.8B
$1.17M 0.02%
42,428
-886
-2% -$22.4K
XLK icon
638
State Street Technology Select Sector SPDR ETF
XLK
$122B
$1.17M 0.02%
17,988
+1,296
+8% +$78.9K
DHI icon
639
D.R. Horton
DHI
$41B
$1.17M 0.02%
16,927
-3,392
-17% -$247K
HLIO icon
640
Helios Technologies
HLIO
$2.69B
$1.17M 0.02%
21,847
-440
-2% -$20.7K
MNRO icon
641
Monro
MNRO
$368M
$1.17M 0.02%
21,867
-1,587
-7% -$72.5K
PETQ
642
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$1.16M 0.02%
30,218
+7,610
+34% +$236K
SLAB icon
643
Silicon Laboratories
SLAB
$7.2B
$1.16M 0.02%
9,107
+2,203
+32% +$248K
AMP icon
644
Ameriprise Financial
AMP
$49.2B
$1.16M 0.02%
5,968
+173
+3% +$31K
SCS
645
DELISTED
Steelcase
SCS
$1.16M 0.02%
85,511
-10,895
-11% -$133K
WING icon
646
Wingstop
WING
$3.2B
$1.15M 0.02%
8,687
+1,445
+20% +$189K
OKTA icon
647
Okta
OKTA
$26.2B
$1.15M 0.02%
4,520
+24
+0.5% +$5.7K
ESI icon
648
Element Solutions
ESI
$9.08B
$1.15M 0.02%
64,573
+43,999
+214% +$608K
ATO icon
649
Atmos Energy
ATO
$28.4B
$1.14M 0.02%
11,942
-973
-8% -$93.8K
SIVB
650
DELISTED
SVB Financial Group
SIVB
$1.14M 0.02%
2,928
-15
-0.5% -$4.86K

Similar funds

Oppenheimer Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Oppenheimer Asset Management held 1,189 positions worth $5.99B, up 16% from $5.15B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer Asset Management's Q4 2020 filing shows 99 new, 492 increased, 540 reduced and 55 closed positions. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 42,289 shares worth $8.23M. The largest sale was Unilever NV New York Registry Shares, an estimated $16.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer Asset Management's largest Q4 2020 buy was Vanguard Morningstar Total Stock Market ETF: 42,289 shares worth $8.23M.
  • Oppenheimer Asset Management added most to Unilever in Q4 2020, an estimated $19.2M increase.
  • Oppenheimer Asset Management's biggest Q4 2020 reduction was Amgen, cutting an estimated $6.12M.
  • Oppenheimer Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $16.8M.
  • Oppenheimer Asset Management's ten largest holdings make up 14% of its $5.99B portfolio in Q4 2020.
  • Oppenheimer Asset Management opened 99 new positions and closed 55 in Q4 2020.
  • Oppenheimer Asset Management's portfolio value rose 16% quarter-over-quarter to $5.99B.

Based on Oppenheimer Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.